Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
FibroGen, Inc. (NASDAQ: FGEN) Grants Eluminex Biosciences Exclusively Licensed Global Rights…
9 Meters Biopharma, Inc. (NASDAQ: NMTR) Broadens its Existing Pipeline with…
Agenus Inc (NASDAQ: AGEN) Inks Licensing Deal With Bristol-Myers Squibb Co…
Argentina Makes An Official Announcement Of The COVID-19 Vaccine Supply Deal…
Atossa Therapeutics Inc (NASDAQ: ATOS) Granted Regulatory Approval To Open Clinical…
Finance
Brooklyn Immunotherapeutics Inc (NYSEAMERICAN:BTX) Clinches An Exclusive License mRNA Gene Editing…
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From…
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,…
GeoVax Labs (GOVX) surges on positive sentiment
Compass Pathways (CMPS) could lead psychedelic sector
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
ChemoCentryx Inc
Tag: ChemoCentryx Inc
ChemoCentryx Inc (NASDAQ:CCXI) Files New Drug Application For Avacopan As An...
Matt Wade
-
July 20, 2020
0
.td-post-views{ display: none !important; }
